Case studies

The Queensland Government’s Chemistry Centre at BRIJ plays a vital role in protecting the reef, with world-class expertise in environmental and agricultural chemistry backed by over a century of experience and accreditation from the National Association of Testing Authorities.

The Gardasil vaccine exemplifies Australian research commercialisation at its finest and showcases the extraordinary investment returns possible at BRIJ.

Sanofi and the Queensland Government are establishing a A$280m Translational Science Hub to position Queensland as a global leader in mRNA vaccine development.

Microbio and the Translational Research Institute are advancing critical diagnostic technologies to combat sepsis through revolutionary pathogen detection methods.

Microba and the Translational Research Institute are pioneering advanced gut microbiome analysis through proprietary metagenomic technology that surpasses conventional sequencing methods.

Vaxxas is pioneering a revolutionary approach to vaccinations with its high-density microarray patch (HD-MAP) technology.

Infensa Bioscience research transforms spider venom into a world-first cardioprotective drug to prevent cell death during heart attack.

At BRIJ’s Ecosciences Precinct, CSIRO researchers are pioneering innovative enzymatic technologies to combat plastic waste.